Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Other Non Operating Income (2021 - 2026)

HeartSciences filings provide 6 years of Other Non Operating Income readings, the most recent being $5241.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 64.24% to $5241.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $17143.0, a 87.34% decrease, with the full-year FY2025 number at $87795.0, up 60.67% from a year prior.
  • Other Non Operating Income hit $5241.0 in Q1 2026 for HeartSciences, up from $2168.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $249349.0 in Q2 2022 to a low of $3.0 in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was $2490.5 (2025), compared with a mean of $25294.6.
  • Biggest five-year swings in Other Non Operating Income: crashed 99.9% in 2023 and later surged 657000.0% in 2024.
  • HeartSciences' Other Non Operating Income stood at $1199.0 in 2022, then plummeted by 99.75% to $3.0 in 2023, then surged by 657000.0% to $19713.0 in 2024, then tumbled by 89.0% to $2168.0 in 2025, then soared by 141.74% to $5241.0 in 2026.
  • The last three reported values for Other Non Operating Income were $5241.0 (Q1 2026), $2168.0 (Q4 2025), and $2813.0 (Q3 2025) per Business Quant data.